skip navigation

This website uses CSS layout which is not compatible with your current browser. Please consider using a more up to date browser to view this site.

Event Calendar

July

Close [X]

Beyond Boundaries

From: 4 July 2009
Until: 5 July 2009
Location: Farnborough

 

July

Close [X]

Beyond Boundaries

From: 4 July 2009
Until: 5 July 2009
Location: Farnborough

 

July

Close [X]

MS Society Information day

9 July 2009, Homerton University Hospital, Education Centre, Homerton Row, London E9 6SR

 

July

Close [X]

L'Etape du Tour

20 July 2009, Montelimar to Mont Ventoux

 

September

Close [X]

AGM 2009

From: 12 September 2009
Until: 13 September 2009
Location: Sofietel London, Heathrow

 

September

Close [X]

AGM 2009

From: 12 September 2009
Until: 13 September 2009
Location: Sofietel London, Heathrow

 

October

Close [X]

Primary Progressive Information Day (Hinckley 2009)

3 October 2009, Hinckley Island Barcelo Hotel

 

July 2009

      123 4
5 678 9 1011
12131415161718
19 20 2122232425
262728293031 

August 2009

      1
2345678
9101112131415
16171819202122
23242526272829
3031     

September 2009

  12345
67891011 12
13 141516171819
20212223242526
27282930   

October 2009

    12 3
45678910
11121314151617
18192021222324
25262728293031

November 2009

1234567
891011121314
15161718192021
22232425262728
2930     

December 2009

  12345
6789101112
13141516171819
20212223242526
2728293031  

January 2010

     12
3456789
10111213141516
17181920212223
24252627282930
31      

February 2010

 123456
78910111213
14151617181920
21222324252627
28      

March 2010

 123456
78910111213
14151617181920
21222324252627
28293031   

April 2010

    123
45678910
11121314151617
18192021222324
252627282930 

May 2010

      1
2345678
9101112131415
16171819202122
23242526272829
3031     

June 2010

  12345
6789101112
13141516171819
20212223242526
27282930   

Tysabri explained

 
 Go to news listing

Tysabri licensed for use in the UK

29 Jun 2006

Tysabri has been licensed for use in the UK today. The drug still needs to be reviewed by NICE and we await to hear as to whether NICE will “fast-track” the appraisal through the new Single Technology Assessment of sixteen weeks, or whether it will go through the longer main stream appraisal which would not complete until October 2007. We hope to hear from NICE on this around the 5 July.

In the meantime, the drug can - in theory - be prescribed by neurologists for people with certain types of MS, dependent on funding.

The European marketing recommendation is that Tysabri be authorised for use as a single disease modifying therapy for people with highly active relapsing remitting MS who have failed to respond to treatment with beta interferon or in patients who have rapidly evolving, severe relapsing remitting MS.

Ken Walker, MS Society acting chief executive, said:

“This is excellent news for people with MS, as Tysabri offers a powerful addition to the existing disease modifying treatments.

We believe that NICE should fast track the approval process under the new Single Technology Assessment.

Our understanding is that Tysabri has been licensed for people with highly active relapsing remitting MS who have failed to respond to treatment with beta interferon or for those who have rapidly evolving, severe relapsing remitting MS. Clearly, this drug will not benefit everyone with MS and we recommend people should seek the advice of their GP or neurologist. Nevertheless, it is a significant breakthrough in MS treatment.”
Related documents
pdf
Tysabri - a new drug for MS (pdf 84kb)
The new drug Tysabri is effective for people with relapsing remitting MS, but use of the drug carries some risk. MS Matters reports.

 BACK TO TOP